Patents by Inventor Tomas Mustelin

Tomas Mustelin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VHR protein tyrosine phosphatase inhibitors, compositions and methods of use
    Patent number: 8188080
    Abstract: Disclosed herein are Vaccinia H1-related (VHR) protein tyrosine phosphatase (PTP) inhibitors that provide a method for treating cancer.
    Type: Grant
    Filed: October 17, 2008
    Date of Patent: May 29, 2012
    Assignee: Sanford-Burnham Medical Research Institute
    Inventors: Tomas Mustelin, Lutz Tautz
  • METHODS FOR TREATING LEUKEMIA AND MYELODYSPLASTIC SYNDROME, AND METHODS FOR IDENTIFYING AGENTS FOR TREATING SAME
    Publication number: 20120095032
    Abstract: The present disclosure relates to methods for treating leukemia, pre-leukemic conditions, as well as myelodysplastic syndrome and acute myelogenous leukemia. The present disclosure further relates to compounds that can be used for treating leukemia, pre-leukemic conditions, as well as myelodysplastic syndrome and acute myelogenous leukemia. The present disclosure also relates to methods for identifying compounds that can be used for treating leukemia, pre-leukemic conditions, as well as myelodysplastic syndrome.
    Type: Application
    Filed: December 6, 2011
    Publication date: April 19, 2012
    Inventors: Tomas Mustelin, Lutz Tautz, Nicolas David Peter Cosford, Eduard Sergienko
  • Methods for treating leukemia and myelodysplastic syndrome, and methods for identifying agents for treating same
    Publication number: 20090105240
    Abstract: The present disclosure relates to methods for treating leukemia, pre-leukemic conditions, as well as myelodysplastic syndrome and acute myelogenous leukemia. The present disclosure further relates to compounds that can be used for treating leukemia, pre-leukemic conditions, as well as myelodysplastic syndrome and acute myelogenous leukemia. The present disclosure also relates to methods for identifying compounds that can be used for treating leukemia, pre-leukemic conditions, as well as myelodysplastic syndrome.
    Type: Application
    Filed: October 17, 2007
    Publication date: April 23, 2009
    Inventors: Tomas Mustelin, Lutz Tautz, Nicholas David Peter Cosford, Eduard Sergienko
  • VHR PROTEIN TYROSINE PHOSPHATASE INHIBITORS, COMPOSITIONS AND METHODS OF USE
    Publication number: 20090105254
    Abstract: Disclosed herein are Vaccinia H1-related (VHR) protein tyrosine phosphatase (PTP) inhibitors that provide a method for treating cancer.
    Type: Application
    Filed: October 17, 2008
    Publication date: April 23, 2009
    Applicant: BURNHAM INSTITUTE FOR MEDICAL RESEARCH
    Inventors: Tomas Mustelin, Lutz Tautz